Old Web
English
Sign In
Acemap
>
authorDetail
>
David Ramirez
David Ramirez
University of Texas MD Anderson Cancer Center
Oncology
Medicine
Internal medicine
Massage
Chemotherapy-induced peripheral neuropathy
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I safety and efficacy study of autophagy inhibition with hydroxychloroquine to augment the antiproliferative and biological effects of preoperative palbociclib plus letrozole for estrogen receptor-positive, HER2-negative metastatic breast cancer (MBC).
2021
Journal of Clinical Oncology
Akshara Singareeka Raghavendra
Danielle N. Kwiatkowski
Senthil Damodaran
Nicole M. Kettner
David Ramirez
Dan S. Gombos
Kelly K. Hunt
Yu Shen
Khandan Keyomarsi
Debu Tripathy
Show All
Source
Cite
Save
Citations (0)
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.
2020
Investigational New Drugs
Clinton Yam
Gaiane M. Rauch
Tanbin Rahman
Meghan Sri Karuturi
Elizabeth Ravenberg
Jason B White
A Clayborn
Pamela McCarthy
Sausan Abouharb
Bora Lim
Jennifer K. Litton
David Ramirez
Sadia Saleem
James Stec
W. Fraser Symmans
Lei Huo
Senthil Damodaran
Ryan Sun
Stacy L. Moulder
Show All
Source
Cite
Save
Citations (3)
A pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy (CIPN).
2019
Journal of Clinical Oncology
Gabriel Lopez
Cathy Eng
Michael J. Overman
David Ramirez
Wenli Liu
Curtiss M Beinhorn
Pamela A Sumler
Sarah Prinsloo
Minxing Chen
Yisheng Li
Eduardo Bruera
Lorenzo Cohen
Show All
Source
Cite
Save
Citations (0)
1